JF
SWTX

Jump Financial’s SpringWorks Therapeutics SWTX Stock Holding History

Jump Financial’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,075
Closed -$201K – 2242
2024
Q1 		$201K Buy
+4,075
New +$188K 0.01% 1688
2023
Q2 		– Sell
-12,900
Closed -$332K – 2149
2023
Q1 		$332K Sell
12,900
-34,421
-73% -$1.01M 0.01% 1070
2022
Q4 		$1.23M Buy
47,321
+33,716
+248% +$831K 0.06% 396
2022
Q3 		$388K Sell
13,605
-27,495
-67% -$788K 0.02% 1010
2022
Q2 		$1.01M Buy
+41,100
New +$1.5M 0.04% 570

Other funds holding SWTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Jump Financial's SWTX Position: Q2 2024 in Review

Jump Financial sold out of SpringWorks Therapeutics (SWTX) in Q2 2024, closing a stake of 4,075 shares — an estimated $201K sold.

Jump Financial first reported a position in SWTX in Q2 2022 and held it in 5 quarters. The position peaked at $1.23M in Q4 2022. 209 funds tracked by Wall St. Rank hold SWTX as of Q2 2024.

  • Jump Financial reported no remaining SpringWorks Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Jump Financial sold 4,075 SpringWorks Therapeutics shares in Q2 2024, an estimated $201K.
  • Jump Financial first reported a position in SpringWorks Therapeutics in Q2 2022 and held it in 5 quarters.
  • Jump Financial's SpringWorks Therapeutics position peaked at $1.23M in Q4 2022.
  • 209 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2024.

Based on Jump Financial's 13F filing for Q2 2024, filed 14 Aug 2024.